ALX-0171: Phase I data

A double-blind, placebo-controlled, Dutch Phase I trial in 60 healthy males showed that single ascending-doses of 2.1-210 mg ALX-0171 (n=44) and multiple ascending-doses of twice-daily 140 and 210 mg ...